Abstract
Recognizing immune responses to oncolytic virotherapy opens the way for new combinations.
MeSH terms
-
Animals
-
Antineoplastic Agents, Immunological / therapeutic use
-
Combined Modality Therapy
-
Humans
-
Immunotherapy*
-
Neoplasms / immunology
-
Neoplasms / therapy*
-
Neoplasms / virology
-
Oncolytic Virotherapy*
-
Oncolytic Viruses / genetics
-
Oncolytic Viruses / immunology
-
Oncolytic Viruses / physiology*
-
Randomized Controlled Trials as Topic
Substances
-
Antineoplastic Agents, Immunological